ProPhase Labs' US stock price rose by more than 35%, and its market value rose to US$15.78 million.
-
最新报道：According to Rockflow data, on August 13, US medical technology company ProPhase Labs saw its stock price surge over 35% during trading, bringing its market capitalization to $15.78 million. The stock had previously surged over 40% in pre-market trading. ProPhase Labs announced on July 21 that it was exploring a reverse merger with a cryptocurrency-focused firm and would begin holding Bitcoin as part of a new digital asset reserve strategy.
下一篇
XRP Stumbles, But A Recovery Could Be Around The Corner
- CRYPTOWZRD noted XRP closed bearishly as Bitcoin Dominance rose, but anticipates a swift r...
24小时热点
热点专题
407106